Figure 2From: Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial Overall study flow of the 'STem cell Application Researches and Trials In NeuroloGy-2’ (STARTING-2) study. *Indicates 1 day before mesenchymal stem cell (MSC) infusion in the MSC group vs 30 days (± 2 days) after randomization in the control group.Back to article page